Stay updated on All-Case Surveillance of Ofev in Patients With IPF in Japan Clinical Trial
Sign up to get notified when there's something new on the All-Case Surveillance of Ofev in Patients With IPF in Japan Clinical Trial page.

Latest updates to the All-Case Surveillance of Ofev in Patients With IPF in Japan Clinical Trial page
- Check2 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check9 days agoChange DetectedA banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology, while the study page remains an error page.SummaryDifference1%

- Check16 days agoChange DetectedThe 403 Forbidden page's footer revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check23 days agoChange DetectedThe footer’s site revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check37 days agoChange DetectedA 403 Forbidden page now appears instead of the previous study content, indicating that access to the study record is blocked. This reflects a permission or access issue rather than a change to the page's substantive information.SummaryDifference0.5%

- Check44 days agoChange DetectedThe page now shows a 403 Forbidden error and standard site chrome, replacing the previous study content; several related-info items, sponsor references, and study documents have been removed to reflect restricted access to the record.SummaryDifference17%

Stay in the know with updates to All-Case Surveillance of Ofev in Patients With IPF in Japan Clinical Trial
Enter your email address, and we'll notify you when there's something new on the All-Case Surveillance of Ofev in Patients With IPF in Japan Clinical Trial page.